FDA 执法报告 D-0050-2027 将 Shenzhen Techdow 肝素钠注射液召回列为 II 类
FDA drug enforcement D-0050-2027: Shenzhen Techdow Pharmaceutical Co., Ltd. — Lack of Assurance of Sterility
FDA 执法报告 D-0050-2027 将 Shenzhen Techdow Pharmaceutical 的肝素钠注射液召回列为 II 类,原因为无菌保证不足。
记录列出该肝素钠注射液召回的分类级别、涉事批次与分销范围,可作为无菌保证缺陷召回档案的参照。
FDA drug recall enforcement report — D-0050-2027
Report issued: 2026-10-28. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "19 Gaoxinzhongyi Road",
"address_2": "Nanshan District",
"center_classification_date": "20261016",
"city": "Shenzhen",
"classification": "Class II",
"code_info": "Lot# CU03232A, Exp 1/31/2028",
"country": "China",
"distribution_pattern": "Nationwide in the USA.",
"event_id": "100049",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"ANDA202957"
],
"brand_name": [
"HEPARIN SODIUM"
],
"generic_name": [
"HEPARIN SODIUM"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Hepalink USA Inc."
],
"package_ndc": [
"81952-113-01",
"81952-113-06",
"81952-113-03",
"81952-113-08",
"81952-116-01",
"81952-116-06",
"81952-112-01",
"81952-112-06",
"81952-112-04",
"81952-112-09",
"81952-112-05",
"81952-112-10",
"81952-111-01",
"81952-111-06",
"81952-115-02",
"81952-115-07",
"81952-114-04",
"81952-114-09",
"81942-111-01"
],
"product_ndc": [
"81952-111",
"81952-113",
"81952-116",
"81952-112",
"81952-115",
"81952-114"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"rxcui": [
"1361226",
"1361574",
"1361615",
"1362831",
"1658647"
],
"spl_id": [
"2e8e07a4-763e-79e5-e063-6394a90a7619"
],
"spl_set_id": [
"c4c6bc1f-e0c7-fd0d-e053-2995a90abdef"
],
"substance_name": [
"HEPARIN SODIUM"
],
"unii": [
"ZZ45AB24CA"
],
"upc": [
"0381952113018",
"0381952115074",
"0381952116019",
"0381952112103",
"0381952116064",
"0381952112059",
"0381952114091",
"0381952113063",
"0381952113032",
"0381952114046",
"0381952112042",
"0381952112097",
"0381952113087",
"0381952112066",
"0381952111069"
]
},
"postal_code": "N/A",
"product_description": "Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01",
"product_quantity": "251,000 1 mL multidose vials",
"product_type": "Drugs",
"reason_for_recall": "Lack of Assurance of Sterility",
"recall_initiation_date": "20261001",
"recall_number": "D-0050-2027",
"recalling_firm": "Shenzhen Techdow Pharmaceutical Co., Ltd.",
"report_date": "20261028",
"state": "",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov